Taxol Hypersensitivity: Rapid Retreatment Is Safe and Cost Effective
- 31 January 1998
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 68 (1) , 25-28
- https://doi.org/10.1006/gyno.1997.4906
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- Anaphylaxis to carboplatin following multiple previous uncomplicated courses.Gynecologic Oncology, 1995
- Paclitaxel-Associated Hypersensitivity Reaction despite High-Dose Steroids and Prolonged InfusionsGynecologic Oncology, 1995
- A Mixed Micellar Formulation Suitable for the Parenteral Administration of TaxolPharmaceutical Research, 1994
- Paclitaxel rechallenge failure after a major hypersensitivity reaction.Journal of Clinical Oncology, 1993
- Hypersensitivity reactions from taxol.Journal of Clinical Oncology, 1990
- Pretreatment of high-risk patients requiring radiographic contrast media studiesJournal of Allergy and Clinical Immunology, 1981